133 related articles for article (PubMed ID: 2144744)
1. Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival.
O'Reilly SM; Richards MA; Rubens RD
Eur J Cancer; 1990; 26(5):574-7. PubMed ID: 2144744
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.
Twelves CJ; Dobbs NA; Michael Y; Summers LA; Gregory W; Harper PG; Rubens RD; Richards MA
Br J Cancer; 1992 Oct; 66(4):765-9. PubMed ID: 1419619
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for patients with liver metastases from breast cancer.
Eichbaum MH; Kaltwasser M; Bruckner T; de Rossi TM; Schneeweiss A; Sohn C
Breast Cancer Res Treat; 2006 Mar; 96(1):53-62. PubMed ID: 16319993
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer--a retrospective analysis.
Baur M; Schlappack O; Havelec L; Wrba F; Dittrich C
Acta Med Austriaca; 2001; 28(5):135-40. PubMed ID: 11774775
[TBL] [Abstract][Full Text] [Related]
5. Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer.
Kamby C; Dirksen H; Vejborg I; Daugaard S; Guldhammer B; Rossing N; Mouridsen HT
Cancer; 1987 Apr; 59(8):1524-9. PubMed ID: 3545442
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and survival analysis of breast cancer molecular subtypes with hepatic metastases.
Ge QD; Lv N; Kong YN; Xie XH; He N; Xie XM; Wei WD
Asian Pac J Cancer Prev; 2012; 13(10):5081-6. PubMed ID: 23244114
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
[TBL] [Abstract][Full Text] [Related]
8. The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases.
Martinez SR; Young SE; Giuliano AE; Bilchik AJ
Am J Surg; 2006 Feb; 191(2):281-3. PubMed ID: 16442961
[TBL] [Abstract][Full Text] [Related]
9. Surgical and nonsurgical management of primary and metastatic liver tumors.
Zibari GB; Riche A; Zizzi HC; McMillan RW; Aultman DF; Boykin KN; Gonzalez E; Nandy I; Dies DF; Gholson CF; Holcombe RF; McDonald JC
Am Surg; 1998 Mar; 64(3):211-20; discussion 220-1. PubMed ID: 9520809
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of computerised tomography findings in women with liver metastases from breast cancer.
Mhlanga JC; Evans AE; Doyle S; James JJ; Cornford EJ; Balls G; Chan SY; Ellis I
Breast; 2011 Oct; 20(5):455-9. PubMed ID: 21596564
[TBL] [Abstract][Full Text] [Related]
12. Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases.
Xu Z; Schlesinger D; Toulmin S; Rich T; Sheehan J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):612-8. PubMed ID: 22436795
[TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of steroid receptor status for disease free and overall survival after surgical resection of isolated liver metastasis in breast cancer patients.
Zegarac M; Nikolic S; Gavrilovic D; Kolarevic D; Jevric M; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Markovic I; Buta M; Ninkovic S; Dzodic R
J BUON; 2017; 22(1):192-199. PubMed ID: 28365954
[TBL] [Abstract][Full Text] [Related]
14. Epirubicin in breast cancer patients with liver metastases and abnormal liver biochemistry: initial weekly treatment followed by rescheduling and intensification.
Twelves CJ; Richards MA; Smith P; Rubens RD
Ann Oncol; 1991 Oct; 2(9):663-6. PubMed ID: 1742222
[TBL] [Abstract][Full Text] [Related]
15. Breast liver metastases--incidence, diagnosis and outcome.
Hoe AL; Royle GT; Taylor I
J R Soc Med; 1991 Dec; 84(12):714-6. PubMed ID: 1774744
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
[TBL] [Abstract][Full Text] [Related]
17. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the syndrome of acute liver failure caused by metastases from breast carcinoma.
Mogrovejo E; Manickam P; Amin M; Cappell MS
Dig Dis Sci; 2014 Apr; 59(4):724-36. PubMed ID: 24370782
[TBL] [Abstract][Full Text] [Related]
19. Contrasting liver function test patterns in obstructive jaundice due to biliary strictures [corrected] and stones.
Hayat JO; Loew CJ; Asrress KN; McIntyre AS; Gorard DA
QJM; 2005 Jan; 98(1):35-40. PubMed ID: 15625352
[TBL] [Abstract][Full Text] [Related]
20. The clinical course of bone metastases from breast cancer.
Coleman RE; Rubens RD
Br J Cancer; 1987 Jan; 55(1):61-6. PubMed ID: 3814476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
